|
Volume 271, Number 32,
Issue of August 9, 1996
pp. 19503-19508
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Dopamine D1A Receptor Regulation of Phospholipase C
Isoform
(Received for publication, March 25, 1996, and in revised form, May 16, 1996)
Pei-Ying
Yu
,
Gilbert M.
Eisner
§
,
Ikuyo
Yamaguchi
¶
,
M. Maral
Mouradian
,
Robin A.
Felder
¶
and
Pedro A.
Jose
§
From the Department of Pediatrics, Georgetown
University Medical Center and the § Department of Physiology
and Biophysics, Georgetown University School of Medicine, Washington,
D. C. 20007, the ¶ Department of Pathology, University of
Virginia School of Medicine, Charlottesville, Virginia 22908, and the
Genetic Pharmacology Unit, NINDS, National Institutes of
Health, Bethesda, Maryland 20892
In LTK cells stably transfected
with rat D1A receptor cDNA, fenoldopam, a
D1 agonist, increased phosphatidylinositol 4,5-bisphosphate
hydrolysis in a time-dependent manner. In the cytosol,
phospholipase C (PLC) activity increased (50 ± 7%) in 30 s,
returned to basal level at 4 h, and decreased below basal values
by 24 h; in the membrane, PLC activity also increased (36 ± 13%) in 30 s, returned to basal level at 10 min, and decreased
below basal value at 4 and 24 h. Fenoldopam also increased PLC-
protein in a time-dependent manner. The latter was blocked
by the D1 antagonist SKF83742 and by a D1A
antisense oligodeoxynucleotide, indicating involvement of the
D1A receptor. The fenoldopam-induced increase in PLC-
and activity was mediated by protein kinase A (PKA) since it was
blocked by the PKA antagonist
Rp-8-CTP-adenosine cyclic
3 :5 -monophosphorothioate (Rp-8-CTP-cAMP-S)
and mimicked by direct stimulation of adenylyl cyclase with forskolin
or by a PKA agonist, Sp-cAMP-S. Protein kinase
C (PKC) was also involved, since the fenoldopam-induced increase in
PLC- protein was blocked by two different PKC inhibitors, calphostin
C and chelerythrine; calphostin C also blocked the fenoldopam-induced
increase in PLC activity. In addition, forskolin and a PKA agonist,
Sp-8-CTP-cAMP-S, increased PKC activity, and
direct stimulation of PKC with phorbol 12-myristate 13-acetate
increased PLC- protein and activity, effects that were blocked by
calphostin C. We suggest that the D1A-mediated stimulation
of PLC occurs as a result of PKA activation. PKA then stimulates
PLC- in cytosol and membrane via activation of PKC.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Yao, P. Fan, Z. Jiang, A. Gordon, D. Mochly-Rosen, and I. Diamond
Dopamine and Ethanol Cause Translocation of {epsilon}PKC Associated with {epsilon}RACK: Cross-Talk between cAMP-Dependent Protein Kinase A and Protein Kinase C Signaling Pathways
Mol. Pharmacol.,
April 1, 2008;
73(4):
1105 - 1112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Chen, J. D. Bohanick, M. Nishihara, J. K. Seamans, and C. R. Yang
Dopamine D1/5 Receptor-Mediated Long-Term Potentiation of Intrinsic Excitability in Rat Prefrontal Cortical Neurons: Ca2+-Dependent Intracellular Signaling
J Neurophysiol,
March 1, 2007;
97(3):
2448 - 2464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zeng, Y. Liu, Z. Wang, D. He, L. Huang, P. Yu, S. Zheng, J. E. Jones, L. D. Asico, U. Hopfer, et al.
Activation of D3 Dopamine Receptor Decreases Angiotensin II Type 1 Receptor Expression in Rat Renal Proximal Tubule Cells
Circ. Res.,
September 1, 2006;
99(5):
494 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose
Functional genomics of the dopaminergic system in hypertension
Physiol Genomics,
November 17, 2004;
19(3):
233 - 246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pedrosa, P. Gomes, U. Hopfer, P. A. Jose, and P. Soares-da-Silva
Gi{alpha}3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event
Am J Physiol Renal Physiol,
November 1, 2004;
287(5):
F1059 - F1066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Lee, C. H. So, A. J. Rashid, G. Varghese, R. Cheng, A. J. Lanca, B. F. O'Dowd, and S. R. George
Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal
J. Biol. Chem.,
August 20, 2004;
279(34):
35671 - 35678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zeng, D. Wang, L. D. Asico, W. J. Welch, C. S. Wilcox, U. Hopfer, G. M. Eisner, R. A. Felder, and P. A. Jose
Aberrant D1 and D3 Dopamine Receptor Transregulation in Hypertension
Hypertension,
March 1, 2004;
43(3):
654 - 660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zeng, D. Wang, Z. Yang, Z. Wang, L. D. Asico, C. S. Wilcox, G. M. Eisner, W. J. Welch, R. A. Felder, and P. A. Jose
Dopamine D1 Receptor Augmentation of D3 Receptor Action in Rat Aortic or Mesenteric Vascular Smooth Muscles
Hypertension,
March 1, 2004;
43(3):
673 - 679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zeng, L. D. Asico, X. Wang, U. Hopfer, G. M. Eisner, R. A. Felder, and P. A. Jose
Angiotensin II Regulation of AT1 and D3 Dopamine Receptors in Renal Proximal Tubule Cells of SHR
Hypertension,
March 1, 2003;
41(3):
724 - 729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Lezcano and C. Bergson
D1/D5 Dopamine Receptors Stimulate Intracellular Calcium Release in Primary Cultures of Neocortical and Hippocampal Neurons
J Neurophysiol,
April 1, 2002;
87(4):
2167 - 2175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Feraille and A. Doucet
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Physiol Rev,
January 1, 2001;
81(1):
345 - 418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nowicki, M. S. Kruse, H. Brismar, and A. Aperia
Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells
Am J Physiol Cell Physiol,
December 1, 2000;
279(6):
C1812 - C1818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xu, X. X. Li, F. E. Albrecht, U. Hopfer, R. M. Carey, and P. A. Jose
Dopamine1 Receptor, Gs{alpha}, and Na+-H+ Exchanger Interactions in the Kidney in Hypertension
Hypertension,
September 1, 2000;
36(3):
395 - 399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-Q. Wang, R. A. Felder, and R. M. Carey
Selective Inhibition of the Renal Dopamine Subtype D1A Receptor Induces Antinatriuresis in Conscious Rats
Hypertension,
January 1, 1999;
33(1):
504 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhen, K. Uryu, H.-Y. Wang, and E. Friedman
D1 Dopamine Receptor Agonists Mediate Activation of p38 Mitogen-Activated Protein Kinase and c-Jun Amino-Terminal Kinase by a Protein Kinase A-Dependent Mechanism in SK-N-MC Human Neuroblastoma Cells
Mol. Pharmacol.,
September 1, 1998;
54(3):
453 - 458.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON
Dopamine Receptors: From Structure to Function
Physiol Rev,
January 1, 1998;
78(1):
189 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Yamaguchi, L. Yao, H. Sanada, R. Ozono, M. M. Mouradian, P. A. Jose, R. M. Carey, and R. A. Felder
Dopamine D1A Receptors and Renin Release in Rat Juxtaglomerular Cells
Hypertension,
April 1, 1997;
29(4):
962 - 968.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Gomes and P. Soares-da-Silva
Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na+-K+-ATPase activity
Am J Physiol Renal Physiol,
June 1, 2002;
282(6):
F1084 - F1096.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|